$160.790.19%-0.31
After Hours: 161.10+0.31 +0.19%
Novartis Ag Adr (NVS)
Date: 2026-10-30 16:00O: 162.53H: 164.06L: 160.40C: 160.79Vol: 3.153M
Novartis Ag Adr stock is traded at $160.79, with a volume of 3,152,741. It is down -0.19% in the last 24 hours and up +12.78% over the past month. Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
Previous Close:
$161.10
Open:
$162.53
24h Volume:
3,152,741
Relative Volume:
1.28
Market Cap:
$303.67B
Revenue:
$54.66B
Net Income/Loss:
$13.58B
P/E Ratio:
22.91
EPS:
$7.02
Net Cash Flow:
$16.05B
1W Performance:
+6.40%
1M Performance:
+12.78%
6M Performance:
+8.75%
1Y Performance:
+31.14%
1-Day Range:
$160.40$164.06
1-Week Range:
$154.11$164.06
52-Week Range:
$121.98$170.46
Novartis Ag Adr Stock (NVS) Company Profile
Compare NVS vs LLY, JNJ, ABBV, MRK
Novartis Ag Adr Stock (NVS) Upgrades & Downgrades
Novartis Ag Adr Stock (NVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Novartis Ag Adr Stock (NVS) Insider Trading
- Bulto Carulla VictorApr 30 '26Officer
- Transaction
- Proposed Sale
- Cost
- $148.10
- #Shares
- 6,800
- Value ($)
- 1,007,093
- #Shares Total
- 0
- Marshall FionaFeb 12 '26Officer
- Transaction
- Proposed Sale
- Cost
- $161.35
- #Shares
- 30,743
- Value ($)
- 4,960,277
- #Shares Total
- 0
- Bulto Carulla VictorFeb 09 '26Officer
- Transaction
- Proposed Sale
- Cost
- $156.21
- #Shares
- 7,500
- Value ($)
- 1,171,576
- #Shares Total
- 0